Unavailable
Unavailable
Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/25/2023 | $5.00 | Buy | BTIG Research |
| 3/11/2022 | $18.00 → $14.00 | Market Outperform | JMP Securities |
| 3/10/2022 | $20.00 → $16.00 | Buy | BTIG |
| 11/8/2021 | $18.50 → $18.00 | Market Outperform | JMP Securities |
4 - SURO CAPITAL CORP. (0001509470) (Issuer)
4 - SURO CAPITAL CORP. (0001509470) (Issuer)
4 - SURO CAPITAL CORP. (0001509470) (Issuer)
3 - SURO CAPITAL CORP. (0001509470) (Issuer)
4 - SURO CAPITAL CORP. (0001509470) (Issuer)
4 - SURO CAPITAL CORP. (0001509470) (Issuer)
8-K - SURO CAPITAL CORP. (0001509470) (Filer)
8-K - SURO CAPITAL CORP. (0001509470) (Filer)
8-K - SURO CAPITAL CORP. (0001509470) (Filer)
BTIG Research resumed coverage of SuRo Capital with a rating of Buy and set a new price target of $5.00
JMP Securities reiterated coverage of SuRo Capital with a rating of Market Outperform and set a new price target of $14.00 from $18.00 previously
BTIG reiterated coverage of SuRo Capital with a rating of Buy and set a new price target of $16.00 from $20.00 previously
NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- SuRo Capital Corp. ("SuRo Capital") (NASDAQ:SSSS) today announced that it will report its financial results for the quarter ended June 30, 2025 after the close of the U.S. market on Wednesday, August 6, 2025. Management will hold a conference call and webcast for investors at 2:00 p.m. PT (5:00 p.m. ET). The conference call access number for U.S. participants is 866-580-3963, and the conference call access number for participants outside the U.S. is +1 786-697-3501. The conference ID number for both access numbers is 0912554. Additionally, interested parties can listen to a live webcast of the call from the "Investor Relations" section of SuRo C
Net Asset Value Anticipated to be $9.00 to $9.50 Per Share Board of Directors Declares $0.25 Per Share Cash Dividend NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- SuRo Capital Corp. ("SuRo Capital", the "Company", "we", "us", and "our") (Nasdaq: SSSS) today provided the following preliminary update on its investment portfolio for the second quarter ended June 30, 2025. "The second quarter was SuRo Capital's best quarter since inception, as measured by the appreciation in NAV per share," said Mark Klein, Chairman and Chief Executive Officer of SuRo Capital. "Our performance was largely driven by the public and private markets recognizing the value proposition of AI infrastructu
SuRo Capital Portfolio Investment, CoreWeave, Completes Largest Tech IPO Since 2021 SuRo Capital Portfolio Investment, OpenAI, Closes Largest Venture Raise with $300 Billion Valuation Net Asset Value of $6.66 Per Share as of March 31, 2025 NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- SuRo Capital Corp. ("SuRo Capital", the "Company", "we", "us", and "our") (Nasdaq: SSSS) today announced its financial results for the first quarter ended March 31, 2025. Net assets totaled approximately $156.8 million, or $6.66 per share, at March 31, 2025, as compared $6.68 per share, at December 31, 2024 and $7.17 per share at March 31, 2024. "The past few months have seen some of the most turbule
NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- SuRo Capital Corp. ("SuRo Capital") (NASDAQ:SSSS) today announced that it will report its financial results for the quarter ended June 30, 2025 after the close of the U.S. market on Wednesday, August 6, 2025. Management will hold a conference call and webcast for investors at 2:00 p.m. PT (5:00 p.m. ET). The conference call access number for U.S. participants is 866-580-3963, and the conference call access number for participants outside the U.S. is +1 786-697-3501. The conference ID number for both access numbers is 0912554. Additionally, interested parties can listen to a live webcast of the call from the "Investor Relations" section of SuRo C
Net Asset Value Anticipated to be $9.00 to $9.50 Per Share Board of Directors Declares $0.25 Per Share Cash Dividend NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- SuRo Capital Corp. ("SuRo Capital", the "Company", "we", "us", and "our") (Nasdaq: SSSS) today provided the following preliminary update on its investment portfolio for the second quarter ended June 30, 2025. "The second quarter was SuRo Capital's best quarter since inception, as measured by the appreciation in NAV per share," said Mark Klein, Chairman and Chief Executive Officer of SuRo Capital. "Our performance was largely driven by the public and private markets recognizing the value proposition of AI infrastructu
SuRo Capital Portfolio Investment, CoreWeave, Completes Largest Tech IPO Since 2021 SuRo Capital Portfolio Investment, OpenAI, Closes Largest Venture Raise with $300 Billion Valuation Net Asset Value of $6.66 Per Share as of March 31, 2025 NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- SuRo Capital Corp. ("SuRo Capital", the "Company", "we", "us", and "our") (Nasdaq: SSSS) today announced its financial results for the first quarter ended March 31, 2025. Net assets totaled approximately $156.8 million, or $6.66 per share, at March 31, 2025, as compared $6.68 per share, at December 31, 2024 and $7.17 per share at March 31, 2024. "The past few months have seen some of the most turbule
SAN FRANCISCO, Dec. 30, 2020 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital” or the “Company”) (Nasdaq: SSSS) today announced an adjustment to the conversion rate of its 4.75% Convertible Senior Notes due 2023 (the “Notes”) as a result of the Company’s cash dividend payable on January 15, 2021. Effective as of December 30, 2020, the conversion price applicable to the Notes has been adjusted to $9.42 per share (106.1681 shares of the Company’s common stock per $1,000 principal amount of Notes) from the most recent conversion price of $9.58 per share (104.3390 shares of the Company’s common stock per $1,000 principal amount of Notes), which has been in effect since November 10, 2020.
SC 13D - SURO CAPITAL CORP. (0001509470) (Subject)
SC 13D - SURO CAPITAL CORP. (0001509470) (Subject)
SC 13G/A - SURO CAPITAL CORP. (0001509470) (Subject)